Clinical Trial Update: SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Control on PD-1/PDL-1 Tx [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating SBRT combined with PD-1/PD-L1 inhibiting therapy in advanced solid tumors after disease control on PD-1/PD-L1 therapy has been comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• PD-1/PD-L1 inhibitors (PD-1/PD-L1 inhibitors)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Solid Tumor | Phase 2 | Status: COMPLETED | Results posted: 2021-01-15